ArrePath website screenshot

ArrePath

ArrePath is an AI-driven pharmaceutical company based in Princeton, New Jersey, applying machine learning to accelerate small-molecule drug discovery in infectious disease. Its platform treats heterogeneous, small, and noisy bioactivity datasets as a modeling opportunity, enabling work on novel chemical classes where conventional approaches struggle; a public-data oral bioavailability model lifted a lead series from roughly 22% to 89% bioavailability. Lead programs include an oral LpxH inhibitor for outpatient urinary tract infections (pre-IND targeted mid-2026) and antibacterial programs against non-tuberculous mycobacterial (NTM) lung disease and tuberculosis, plus an early non-infectious discovery effort. ArrePath is a portfolio company of Insight Partners. It publishes no public developer API, documentation, or SDKs; this profile captures company identity and domain-security posture.

ArrePath is profiled on the APIs.io network. Tagged areas include Company, Biotech Therapeutics, Drug Discovery, Artificial Intelligence, and Machine Learning.

ArrePath’s developer surface includes engineering blog, support, and 2 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotech TherapeuticsDrug DiscoveryArtificial IntelligenceMachine LearningInfectious DiseaseAntibacterialsPharmaceuticals

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/arrepath: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Arrepath Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: arrepath
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/arrepath.png
name: ArrePath
description: ArrePath is an AI-driven pharmaceutical company based in Princeton, New Jersey, applying machine learning to
  accelerate small-molecule drug discovery in infectious disease. Its platform treats heterogeneous, small, and noisy bioactivity
  datasets as a modeling opportunity, enabling work on novel chemical classes where conventional approaches struggle; a public-data
  oral bioavailability model lifted a lead series from roughly 22% to 89% bioavailability. Lead programs include an oral LpxH
  inhibitor for outpatient urinary tract infections (pre-IND targeted mid-2026) and antibacterial programs against non-tuberculous
  mycobacterial (NTM) lung disease and tuberculosis, plus an early non-infectious discovery effort. ArrePath is a portfolio
  company of Insight Partners. It publishes no public developer API, documentation, or SDKs; this profile captures company
  identity and domain-security posture.
url: https://raw.githubusercontent.com/api-evangelist/arrepath/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotech Therapeutics
- Drug Discovery
- Artificial Intelligence
- Machine Learning
- Infectious Disease
- Antibacterials
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/arrepath-domain-security.yml
- type: Website
  url: https://arrepath.com/
- type: Blog
  url: https://arrepath.com/news
- type: Support
  url: https://arrepath.com/contact-us
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence